Abstract
Oropharyngeal candidiasis (OC) is a problem that develops in virtually every patient with AIDS. Recurrent OC can cause pain and discomfort, resulting in loss of appetite. Fluconazole is an effective treatment for OC, but most of the literature describes patients who were infected with a single fungal species, usually Candida albicans. Mixed fungal infection in AIDS patients with OC is rarely reported but has been associated with resistance to fluconazole. The investigators report their findings regarding the effect of mixed infection on the outcome of fluconazole therapy for OC.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 379-384 |
| Number of pages | 6 |
| Journal | Infections in Medicine |
| Volume | 15 |
| Issue number | 6 |
| State | Published - Jun 1998 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Candida albicans
- Candidiasis, oropharyngeal
- Fluconazole
- Infection, fungal
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Response of mixed oropharyngeal fungal infections to fluconazole'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS